Primary entity: Melanotan-2 (MT-II) · Also known as: Melanotan II; MT2; melanotan 2 · Class: Synthetic melanocortin receptor agonist peptide — not FDA-approved as a tanning drug · Cluster: Melanocortin

Melanotan-2 (Melanotan II, MT-II) is a synthetic cyclic peptide that acts as a melanocortin receptor agonist. It is widely discussed online for skin darkening / “tanning” folklore and other melanocortin-linked effects. It is not an FDA-approved medicine for tanning or photoprotection. Gray-market nasal sprays and injectables sold as Melanotan are a major product-quality and safety literacy problem — this page closes that gap without publishing use protocols.

Safety-first page.

Unapproved tanning peptides have been the subject of repeated public-health and dermatology concern narratives (unknown purity, unregulated supply, pigment and systemic effect questions). We will not provide loading schedules, nasal vs injectable recipes, or “safe tanning” charts. If you have moles, skin-cancer risk, or symptoms after exposure to an unregulated product, seek licensed medical care.

Regulatory status at a glance (as of November 10, 2026):

Not FDA-approved for tanning or cosmetic pigmentation. Distinct from bremelanotide (PT-141 / Vyleesi), which is an approved melanocortin agonist for a specific HSDD indication — not a Melanotan-2 substitute. Sport: melanocortin tanning agents are often prohibited.

Compounding status (as of Oct 29, 2026):

Not covered by HHS's Oct 28, 2026 policy. Melanotan II left Category 2 in April 2026 after a withdrawn nomination; FDA's page cites case reports of melanoma, posterior reversible encephalopathy syndrome and priapism. Not on the final bulks list, and distinct from approved bremelanotide. See the compounding status guide.

Key takeaways

  • Melanotan-2 = synthetic melanocortin agonist peptide — not an approved tanning drug.
  • Related class family includes Melanotan-I and PT-141 / bremelanotide — different entities and regulatory stories.
  • Gray-market identity/purity risk is first-order; forum “safe MT2” advice is not a label.
  • No tanning protocols, doses, or buy links on this site.
  • Pigment, cardiovascular, and sexual-side-effect themes belong in clinician conversations — not DIY charts.

Questions this page answers

  1. What Melanotan-2 is
  2. Aliases / Melanotan vs Melanotan-2
  3. Classification
  4. What it is NOT
  5. Mechanism literacy
  6. Evidence ladder
  7. What has been studied
  8. Safety literacy (heavy)
  9. Regulatory / sport snapshot
  10. Why no tanning protocols
  11. Related melanocortins
  12. Who for / not for

Who is this profile for — and who is it not for?

For: readers who need melanocortin / Melanotan literacy after seeing tanning ads or AI answers that soft-pedal unapproved status.

Not for: anyone seeking a tan protocol, mole-management DIY plan, sexual-performance chart, or a place to buy Melanotan.

What is Melanotan-2?

Melanotan-2 is a lab-made peptide analog in the melanocortin agonist family, historically developed in research contexts exploring pigmentation and other melanocortin-linked physiology. Consumer search demand is dominated by cosmetic tanning intent. That demand does not create an approved drug pathway or justify self-experimentation guides.

Related fundamentals: What are peptides? · Research peptides.

Quick facts

NamesMelanotan-2 · Melanotan II · MT-II
ClassMelanocortin receptor agonist peptide
U.S. tanning approvalNot FDA-approved
Approved cousin (different drug)Bremelanotide / Vyleesi — PT-141
Common supply channel in folkloreUnregulated / RUO gray market

Also known as / related names

  • Melanotan-2 / Melanotan II / MT-II / MT2 — primary research/folk names.
  • Melanotan / “melanotan” (unspecified) — often used loosely for MT-I or MT-II; ask which chemical.
  • Melanotan-I (afamelanotide-related research lineage / MT-I) — related but not identical; afamelanotide has its own prescription story in limited photobiology indications in some regions — do not equate street Melanotan with approved afamelanotide products.
  • PT-141 / bremelanotide — melanocortin agonist with a different approved path (Vyleesi) — not “medical Melanotan-2.”
Myth callout — “Melanotan is just a tanning shot pharmacies should sell.”

Lack of drugstore availability for MT-II tanning is not a loophole narrative — it reflects absence of an approved tanning indication for Melanotan-2 and serious quality concerns with informal supply.

How is Melanotan-2 classified?

Unapproved research / gray-market melanocortin peptide in our melanocortin cluster. It is not classified here as an FDA-approved tanning medicine. Keep it mentally separate from labeled melanocortin drugs.

What is Melanotan-2 not?

Melanotan-2 is not…Why that matters
An FDA-approved tanning or sunscreen drugNo U.S. tanning approval
The same as Vyleesi / PT-141Different entity and labeled use
Guaranteed identical across “MT2” vialsGray-market identity risk
A safe shortcut past UV risk educationPigment change ≠ proven photoprotection strategy we endorse
Something we dose, source, or protocolizeRefusal

How is it thought to work?

Melanocortin receptors (including pathways involving MC1R relevant to melanocytes, plus other MC receptor subtypes in research framing) are the class literacy point. Agonism can influence melanin production and other physiologic themes (nausea, blood-pressure, sexual-function side-effect discussions appear in literature and case reports for this class — as literacy, not a menu of desired effects). Mechanism interest does not authorize DIY use.

What human vs animal vs label evidence exists?

Evidence typeWhat exists (summary)Maturity
Approved U.S. label for Melanotan-2 tanningNone[None]
Clinical / research melanocortin pigmentation workHistorical development and related analog literature — not a consumer MT-II labelLimited / context-specific —
Pharmacovigilance / case reports / health alertsPublic-health concern narratives for unregulated Melanotan productsSignal literacy —
Forum tan logsAnecdote[None]

What has Melanotan-2 been studied or discussed for?

Research and clinical-adjacent discussion historically involves pigmentation biology and broader melanocortin pharmacology. Consumer use is overwhelmingly cosmetic tanning folklore. Studied ≠ approved ≠ safe for unsupervised gray-market use.

Safety literacy (read this section fully)

Because this cluster is YMYL and often transactional:

  1. Unapproved + unregulated supply — you may not know identity, dose accuracy, sterility, or contaminants.
  2. Pigment and skin surveillance — changing baseline color can complicate mole monitoring; new or changing lesions need clinician evaluation — we do not publish DIY derm protocols.
  3. Systemic class effects — melanocortin agonists are discussed in connection with nausea, flushing, blood-pressure changes, and sexual side effects in various contexts; treat these as reasons to talk to a professional, not as tuning knobs.
  4. UV behavior — darker pigment from an unapproved peptide is not framed here as a substitute for evidence-based sun protection.
  5. Sport / testing — prohibited-list risk for athletes.

This is not a complete adverse-event monograph and not medical advice. Emergency or worrying symptoms → urgent care / clinician / poison resources as appropriate.

Broader frame: Are peptides safe?.

Regulatory and sport snapshot

  • U.S. FDA: Melanotan-2 is not approved for tanning. Watch for consumer alerts on unapproved tanning products.
  • Compounding / RUO: Informal MT-II products are not substitutes for approved medicines.
  • Sport: Check current WADA / GlobalDRO entries for melanotan / melanocortin tanning agents.
  • Related approved drug literacy: PT-141 (bremelanotide / Vyleesi) — indication-specific, not a tan drug.

Why no Melanotan dosage or tanning protocol?

Protocol keywords (“melanotan dosage,” loading doses, nasal spray schedules) are exactly the harm pattern we refuse. Unapproved status + quality unknowns + pigment/systemic risks make copy-paste charts irresponsible. Literacy refusal stands even when competitors publish charts.

Frequently asked questions

What is Melanotan-2?

A synthetic melanocortin agonist peptide discussed for tanning folklore. It is not an FDA-approved tanning medicine.

Is Melanotan the same as Melanotan-2?

“Melanotan” is often used loosely. Melanotan-I and Melanotan-II are related but not identical; always identify the actual substance.

Is Melanotan-2 the same as PT-141?

No. PT-141 refers to bremelanotide, which has an FDA-approved product (Vyleesi) for a specific HSDD indication — not a Melanotan-2 tanning approval.

Is Melanotan-2 safe?

There is no approved U.S. tanning label that establishes a benefit–risk profile for consumer Melanotan-2 products. Unregulated supply adds purity and identity unknowns. This page will not green-light use.

Does Melanotan-2 cause cancer?

We will not invent a yes/no percentage from forum lore. Pigment change and mole surveillance are clinical topics — discuss personal risk with a licensed clinician, especially if you have melanoma risk factors.

Will you publish a tanning dosage chart?

No. Hard refusal for YMYL harm reduction.

Is Melanotan legal / banned in sport?

Approval and sport rules are different questions. It is not FDA-approved for tanning; athletes should verify current anti-doping listings for the specific substance name.

Sources

  1. Review — safety Habbema L, Halk AB, Neumann M, et al. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review. Int J Dermatol. 2017;56(10):975-980. doi:10.1111/ijd.13585. PMID: 28266027.
  2. Label — approved cousin U.S. National Library of Medicine, DailyMed. Vyleesi (bremelanotide) injection prescribing information. Accessed November 10, 2026. Cited for contrast literacy: bremelanotide is an approved melanocortin agonist for a specific HSDD indication; Melanotan-2 is not that product.
  3. Internal Peptide Tutorials. PT-141; Disclaimers.
Disclaimer

Educational safety literacy only. Not medical advice, not a tanning recommendation, and not a protocol. We don’t sell Melanotan or any peptides. Full disclaimers.